3D-Monophosphoryl Lipid (14) |CAS 252042-59-4|DC Chemicals

Cas No.:	252042-59-4
Chemical Name:	3D-Monophosphoryl Lipid (14)
Synonyms:	3D-MPL (14),5A35GQS15R;Phad;Monophosphoryl lipid A (synthetic);Phosphorylated hexaacyl disaccharide;D-Glucose, 2-deoxy-6-O-(2-deoxy-3-O-((3R)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3R)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-O-phosphono-beta-D-glucopyranosyl)-2-(((3R)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-;Unii-5A35gqs15R
SMILES:	P(=O)(O)(O)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1OC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCC)=O)=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCC)=O)=O)OC[C@H]([C@H]([C@@H]([C@H](C=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCCCC)=O)=O)O)O)O
Formula:	C₉₆H₁₈₁N₂O₂₁P
M.Wt:	1730.43893408775
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC67240	KRN-7000(7DW8-5)
DC67239	KRN-7000(S34)
DC67238	KRN-7000(C34)
DC67237	TQL-1055	TQL-1055 is a semi-synthetic analog of the saponin adjuvant QS-21 (HY-101092) and can be used as a prophylactic vaccine adjuvant. TQL-1055 exhibits robust adjuvant activity for influenza antigens. TQL-1055 combined with the acellular pertussis vaccine (aP) shows good tolerance and enhances the antibody response to pertussis toxin (PT) in mice and rabbits. TQL-1055 is promising for research of chronic hepatitis B.
DC67236	QS-7	QS 7 (QS 7 Api) is a saponin compound that can be extracted from the Quillaja saponaria tree. QS 7 activates immune cells, enhances their antigen presentation ability and cytokine secretion. QS 7 can be used as vaccine adjuvant for immunostimulating, anti-tumor, and anti-infectious activities.
DC67235	CPG 7909
DC67233	AYK004-C1	AYK004-C1 is a TLR agonist. AYK004-C1 can be used to prepare immune adjuvants.
DC67232	AYK004-B1	AYK004-B1 is a TLR7 agonist (EC50=0.2265 nM). AYK004-B1 can be used to prepare immune adjuvants.
DC67231	AYK004	AYK004 is a TLR7/8 agonist that enhances immune responses by activating the TLR signaling pathway. AYK004 is an adenine derivative with a favorable hydrophilic-lipophilic balance, which improves the loading capacity and stability in immunoadjuvant systems such as liposomes, while reducing the side effects of the immunoadjuvant system in systemic immunity .
DC67230	AYK005	AYK005 is a TLR7/8 immunologic adjuvant.